Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

CARD11 Mutation Induces Oligoclonal Expansion of T-Cells, and Accelerates ATL Development in Combination with HBZ

Takuro Kameda, MD PhD, Kotaro Shide, MD PhD, Ayako Kamiunten, MD, Tahira Yuki, Masaaki Sekine, MD, Keiichi Akizuki, MD, Tomonori Hidaka, MD, Yoko Kubuki, MD PhD, Midori Sugiyama, Daisuke Morishita, PhD, Kazuya Shimoda, MD PhD

Blood (2020) 136 (Supplement 1): 17–18.

https://doi.org/10.1182/blood-2020-142242

Published: 2020

Journal Articles

The Role of Calreticulin in Normal Hematopoiesis and Neoplastic Hematopoiesis of Myeloproliferative Neoplasms

Kotaro Shide, MD PhD, Takuro Kameda, MD PhD, Ayako Kamiunten, MD, Yoshinori Ozono, MD, Yuki Tahira, MD, Masaaki Sekine, MD, Masaya Ono, MD PhD, Takako Yokomizo, PhD, Sho Kubota, Keiichi Akizuki, MD, Yoko Kubuki, MD PhD, Tomonori Hidaka, MD, Goro Sashida, MD PhD, Kazuya Shimoda, MD PhD

Blood (2019) 134 (Supplement_1): 309.

https://doi.org/10.1182/blood-2019-130034

Published: 2019

Journal Articles

Depletion of Neoplastic CD11b Positive Cells in Jak2 V617F Mutant Mice Reduced Fibrocytes in Bone Marrow and Improved Myelofibrosis

Yoshinori Ozono, MD, Kotaro Shide, MD PhD, Takuro Kameda, MD PhD, Ayako Kamiunten, MD, Yuki Tahira, MD, Masaaki Sekine, MD, Keiichi Akizuki, MD, Kenichi Nakamura, MD, Hisayoshi Iwakiri, MD, Tomonori Hidaka, MD, Yoko Kubuki, MD PhD, Satoru Hasuike, MD PhD, Fumiyo Toyoshima, MD PhD, Akira Sawaguchi, MD PhD, Kenji Nagata, MD PhD, Kazuya Shimoda, MD PhD

Blood (2019) 134 (Supplement_1): 310.

https://doi.org/10.1182/blood-2019-130042

Published: 2019

Journal Articles

Haploinsufficiency of CALR Confers Hematopoietic Stem Cells (HSCs) with a Clonal Advantage over Wild-Type Cells, and, in Setting of Myeloproliferative Neoplasms, Compensates for the Functions of HSCs Impaired By the Calr Mutation

Kotaro Shide, MD PhD, Takuro Kameda, MD, Ayako Kamiunten, MD, Masaaki Sekine, MD, Yoshinori Ozono, MD, Takako Yokomizo, PhD, Keiichi Akizuki, MD, Yuki Tahira, MD, Yoko Kubuki, MD PhD, Tomonori Hidaka, MD, Goro Sashida, MD PhD, Kazuya Shimoda, MD PhD

Blood (2018) 132 (Supplement 1): 97.

https://doi.org/10.1182/blood-2018-99-114304

Published: 2018

Journal Articles

TET2 Mutation Associated with Organ Infiltrations in ATLL

Takuro Kameda, MD, Kotaro Shide, MD PhD, Ayako Kamiunten, MD, Yuki Tahira, MD, Keiichi Akizuki, MD, Masaaki Sekine, MD, Tomonori Hidaka, MD, Yoko Kubuki, MD PhD, Michihiro Hidaka, MD PhD, Atae Utsunomiya, MD PhD, Takayuki Ohshima, Keisuke Kataoka, MD PhD, Seishi Ogawa, MD PhD, Kazuya Shimoda, MD PhD

Blood (2018) 132 (Supplement 1): 1345.

https://doi.org/10.1182/blood-2018-99-118065

Published: 2018

Journal Articles

Mogamulizumab for ATLL in Clinical Practice

Masaaki Sekine, MD, Masaki Takeuchi, MD, Takanori Toyama, MD, Kouichi Maeda, MD, Seiichi Sato, MD, Kiyoshi Yamashita, MD, PhD, Junzo Ishizaki, MD, Akizuki Keiichi, MD, Ayako Kamiunten, MD, Takuro Kameda, MD PhD, Kotaro Shide, MD PhD, Tomonori Hidaka, MD, Yoko Kubuki, MD PhD, Akira Kitanaka, MD PhD, Kazuya Shimoda, MD, PhD

Blood (2016) 128 (22): 2998.

https://doi.org/10.1182/blood.V128.22.2998.2998

Published: 2016

Journal Articles

Physiological Expression of Calr Mutant Increases Cell Growth and Cytokine Independency in Human Cell Lines Expressing Mpl, and Develops Essential Thrombocythemia in Mice

Kotaro Shide, MD PhD, Takuro Kameda, MD PhD, Masaaki Sekine, MD, Ayako Kamiunten, MD, Keiichi Akizuki, MD, Yuki Tahira, MD, Tomonori Hidaka, MD, Yoko Kubuki, MD PhD, Arata Honda, PhD, Akira Sawaguchi, MD PhD, Akira Kitanaka, MD PhD, Kazuya Shimoda, MD, PhD

Blood (2016) 128 (22): 954.

https://doi.org/10.1182/blood.V128.22.954.954

Published: 2016

Journal Articles

Therapies Targeting the MAPK Pathway Improve Bone Marrow (BM) Fibrosis Induced By JAK2V617F

Kotaro Shide, MD PhD, Takuro Kameda, MD, Ayako Kamiunten, MD, Masaaki Sekine, MD, Keiichi Akizuki, MD, Haruko Shimoda, MD PhD, Tomonori Hidaka, MD PhD, Yoko Kubuki, MD, Akira Kitanaka, MD PhD, Kazuya Shimoda, MD PhD

Blood (2014) 124 (21): 162.

https://doi.org/10.1182/blood.V124.21.162.162

Published: 2014

NARROW

CARD11 Mutation Induces Oligoclonal Expansion of T-Cells, and Accelerates ATL Development in Combination with HBZ

The Role of Calreticulin in Normal Hematopoiesis and Neoplastic Hematopoiesis of Myeloproliferative Neoplasms

Depletion of Neoplastic CD11b Positive Cells in Jak2 V617F Mutant Mice Reduced Fibrocytes in Bone Marrow and Improved Myelofibrosis

Haploinsufficiency of CALR Confers Hematopoietic Stem Cells (HSCs) with a Clonal Advantage over Wild-Type Cells, and, in Setting of Myeloproliferative Neoplasms, Compensates for the Functions of HSCs Impaired By the Calr Mutation

TET2 Mutation Associated with Organ Infiltrations in ATLL

Mogamulizumab for ATLL in Clinical Practice

Physiological Expression of Calr Mutant Increases Cell Growth and Cytokine Independency in Human Cell Lines Expressing Mpl, and Develops Essential Thrombocythemia in Mice

Therapies Targeting the MAPK Pathway Improve Bone Marrow (BM) Fibrosis Induced By JAK2V617F

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only